PI 3-kinase p100 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
3-MA serves as a potent autophagy inhibitor by selectively targeting the PI 3-kinase pathway, specifically influencing the p100 subunit. Its mechanism involves disrupting the lipid kinase activity, leading to altered membrane dynamics and vesicle trafficking. The compound exhibits a unique interaction profile, characterized by specific steric hindrance that affects substrate accessibility. This modulation of autophagic flux provides a deeper understanding of cellular homeostasis and metabolic regulation. | ||||||
Lipoteichoic acid | 56411-57-5 | sc-507479 | 5 mg | $248.00 | ||
BAY 80-6946 | 1032568-63-0 | sc-503264 | 5 mg | $551.00 | ||
Chemical that can impact relapsed follicular lymphoma. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
An investigational drug that has been studied in various cancer types. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
An experimental PI3K inhibitor that has been studied in research models for advanced solid tumors. | ||||||
IPI 145 | 1201438-56-3 | sc-488318 | 5 mg | $311.00 | ||
An investigational drug studied in research models for hematological malignancies. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $189.00 | 4 | |
An investigational drug studied in research models for various hematological malignancies. | ||||||
TG100-115 | 677297-51-7 | sc-364634 sc-364634A | 5 mg 100 mg | $245.00 $1836.00 | 1 | |
An experimental PI3K inhibitor tested in research studies for cancer therapy. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $207.00 | 8 | |
An experimental PI3K/mTOR dual inhibitor studied in research for cancer research. | ||||||
SF1126 | 936487-67-1 | sc-391584 sc-391584A | 5 mg 10 mg | $719.00 $1331.00 | 7 | |
An experimental PI3K inhibitor studied in cancer research models. | ||||||